29 July 2021
Principal investigator Dr Chow Ting Soo says the World Health Organization’s (WHO) Solidarity Plus working committee instead plans to test repurposed medication like anti-malaria drug artesunate, as well as anti-inflammatory drugs like imatinib and infliximab, as potential Covid-19 treatments.